Advanced Medical Solutions Group plc
Listed Companies
26 June 2026
Investec acts for Advanced Medical Solutions Group plc on its £715 million recommended cash acquisition
Our role
Our UK Investment Banking & Corporate Broking team is delighted to have acted as Joint Financial Adviser, Rule 3 Adviser, Nominated Adviser and Corporate Broker to Advanced Medical Solutions Group plc (“AMS”) on its £715 million recommended cash acquisition by H.B. Fuller Medical Adhesive Technologies, a wholly-owned subsidiary of H.B. Fuller Company, at a price of 285 pence per AMS Share.
The Acquisition Price represents a premium of approximately 34.8% to the Closing Price of 212 pence per AMS Share on 20 May 2026 (being the last Business Day prior to the commencement of the Offer Period).
The acquisition of AMS is expected to significantly expand H.B. Fuller’s healthcare adhesives platform, increasing its addressable market, commercial reach, innovation and manufacturing capabilities, while delivering meaningful synergies and supporting higher long-term growth and margins.
Gary Clarence, Head of UK Healthcare M&A at Investec, commented: “We are delighted to have supported AMS, a longstanding Investec client of more than 17 years, on this landmark transaction. The recommended acquisition by H.B. Fuller recognises the strength of AMS’ differentiated surgical adhesive technologies, pan-European commercial platform and deep healthcare expertise. It also represents a compelling strategic opportunity to accelerate the growth of the combined healthcare adhesives platform globally, while delivering attractive value for AMS shareholders.”
About H.B. Fuller
H.B. Fuller is the world's largest pure-play adhesives provider, formulating, manufacturing and marketing adhesives, sealants and related specialty products to customers across a broad range of end markets, including aerospace and defence, packaging, hygiene, electronics, construction, transportation and healthcare.
H.B. Fuller operates a diversified global business across three operating segments: 'Hygiene, Health and Consumable Adhesives', 'Engineering Adhesives' and 'Building Adhesive Solutions'. It operates 77 plants and dozens of sales operations across the Americas, Europe, the Middle East, Africa, India and Asia Pacific and employs approximately 7,100 people.
About Advanced Medical Solutions Group plc
Established in 1991, AMS is a leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of adhesive products, including tissue adhesives, internal fixation devices, internal sealants and dressings, formulated biosurgicals including haemostats and antibiotic collagens and mechanical surgical closures.
AMS markets its products under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, LIQUIFIX™, Peters Surgical, Ifabond, Vitalitec, Seal-G®, ActivHeal® and white label. Headquartered in Winsford, UK, AMS employs over 1,800 people across 22 locations, including 17 with manufacturing capabilities and 11 with R&D sites and sells into more than 100 countries worldwide through a network of multinational or regional partners and distributors, as well as via AMS' own direct sales forces.
Want to know more?
Find out more about how our Direct Lending team can support you.
View more deals
Discover more deals from our award winning team.